RecruitingPhase 2NCT05126849
Haploidentical Allogeneic Hematopoietic Stem Cell Transplantation With Post-transplant Cyclophosphamide in Patients With Acquired Refractory Aplastic Anemia or in Relapse After Immunosuppression
Studying Idiopathic aplastic anemia
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Assistance Publique - Hôpitaux de Paris
- Principal Investigator
- Regis Peffault de Latour, Pr
- Intervention
- Allogenic transplantation(other)
- Enrollment
- 31 enrolled
- Eligibility
- 3-35 years · All sexes
- Timeline
- 2022 – 2027
Study locations (18)
- CHU Amiens, Amiens, France
- CHU Angers, Angers, France
- CHU Besancon, Besançon, France
- CHU Bordeaux, Bordeaux, France
- Hôpital du Haut-Lévêque, Bordeaux, France
- CHU Caen, Caen, France
- Hopital Percy, Clamart, France
- CHU Clermont, Clermont-Ferrand, France
- CHU-Estaing_Clermont Ferrand, Clermont-Ferrand, France
- Henri Mondor, Créteil, France
- CHU Grenoble, Grenoble, France
- CHU Lille, Lille, France
- CHU Limoges, Limoges, France
- CHU Lyon Sud, Lyon, France
- IHOP, CHU Lyon, Lyon, France
- +3 more locations on ClinicalTrials.gov
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT05126849 on ClinicalTrials.govOther trials for Idiopathic aplastic anemia
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE1NCT05998408JAK1/2 Inhibitor Ruxolitinib for Relapsed/Refractory Immune Bone Marrow FailureNational Heart, Lung, and Blood Institute (NHLBI)
- RECRUITINGNANCT05012111Natural History of Acquired and Inherited Bone Marrow Failure SyndromesNational Heart, Lung, and Blood Institute (NHLBI)
- RECRUITINGPHASE1, PHASE2NCT03500731Lung and Bone Marrow Transplantation for Lung and Bone Marrow FailurePaul Szabolcs